These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16960149)

  • 21. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.
    Piazza R; Magistroni V; Mogavero A; Andreoni F; Ambrogio C; Chiarle R; Mologni L; Bachmann PS; Lock RB; Collini P; Pelosi G; Gambacorti-Passerini C
    Neoplasia; 2013 May; 15(5):511-22. PubMed ID: 23633923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
    Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
    Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
    Bertolo C; Roa S; Sagardoy A; Mena-Varas M; Robles EF; Martinez-Ferrandis JI; Sagaert X; Tousseyn T; Orta A; Lossos IS; Amar S; Natkunam Y; Briones J; Melnick A; Malumbres R; Martinez-Climent JA
    Br J Haematol; 2013 Sep; 162(5):621-30. PubMed ID: 23795761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.
    Hayashi Y; Iwato M; Arakawa Y; Fujisawa H; Thoma Y; Hasegawa M; Tachibana O; Yamashita J
    J Neurooncol; 2001 Oct; 55(1):51-8. PubMed ID: 11804283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of the 5' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity.
    Lossos IS; Levy R
    Blood; 2000 Feb; 95(4):1400-5. PubMed ID: 10666217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.
    Otsuki T; Yano T; Clark HM; Bastard C; Kerckaert JP; Jaffe ES; Raffeld M
    Blood; 1995 May; 85(10):2877-84. PubMed ID: 7742550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
    Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP
    Mol Cell Biol; 2008 Sep; 28(17):5391-402. PubMed ID: 18573879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
    Gaidano G; Vivenza D; Forconi F; Capello D; Gloghini A; Bhatia K; Gutierrez M; Gallicchio M; Avanzi GC; Fassone L; Ariatti C; Buonaiuto D; Cingolani A; Saglio G; Tirelli U; Larocca LM; Dalla-Favera R; Carbone A
    Genes Chromosomes Cancer; 2000 Feb; 27(2):177-82. PubMed ID: 10612806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.
    Flordal Thelander E; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
    Leuk Res; 2007 Sep; 31(9):1219-30. PubMed ID: 17161458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.
    Mikata R; Fukai K; Imazeki F; Arai M; Fujiwara K; Yonemitsu Y; Zhang K; Nabeya Y; Ochiai T; Yokosuka O
    Oncol Rep; 2010 Jun; 23(6):1701-8. PubMed ID: 20428828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.
    Rossi D; Gaidano G; Gloghini A; Deambrogi C; Franceschetti S; Berra E; Cerri M; Vendramin C; Conconi A; Viglio A; Muti G; Oreste P; Morra E; Paulli M; Capello D; Carbone A
    Br J Haematol; 2003 Nov; 123(3):475-8. PubMed ID: 14617009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
    Gaidano G; Pastore C; Volpe G
    Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.
    Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD
    Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.